Is now a good time to jump in and buy this blue chip star? The post CSL shares are having a tough time recently. Are they a ...

CSL (ASX:CSL) has had a rough three months with its share price down 17%. However, stock prices are usually driven by ...

CSL Limited's financial performance reveals not just growth but a commitment to future innovations. With a total revenue of $22.2 billion, the company allocated $1.43 billion—approximately 9.6% of its ...

Investors are in panic as Australian drug companies could be the next victims in an expansion of the US trade war.

UBS analyst Laura Sutcliffe maintained a Buy rating on CSL (CMXHF – Research Report) today and set a price target of A$310.00. The company’s ...

Jefferies analyst David Stanton maintained a Buy rating on CSL (CMXHF – Research Report) today and set a price target of A$320.00.Stay Ahead of ...

Deccan Gold Mines Ltd, Liberty Shoes Ltd, Texmo Pipes & Products Ltd and CSL Finance Ltd are among the other gainers in the BSE's 'B' group today, 21 April 2025.

Learn More CSL Ltd (ASX: CSL), one of the crown jewels of the Australian healthcare sector, hasn't had the smoothest ride in April. Amid rising macro uncertainty and market volatility, the biotech ...